Therapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.
Joseph C. Cappelleri, PhD, MPH
Advertisement
Articles by Joseph C. Cappelleri, PhD, MPH
Advertisement
Latest Updated Articles
- Therapeutic and Subtherapeutic Dosing of Pregabalin: Medication Adherence, Healthcare Resource Utilization, and Costs
Published: August 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
4
From Mutation to Medicine: Targeted Therapies in Lung Cancer
5
